Antioxidants and Redox Signaling

期刊简介：Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.ARS coverage includes:-ROS/RNS as messengers-Gaseous signal transducers-Hypoxia and tissue oxygenation-microRNA-Prokaryotic systems-Lessons from plant biology

【译文】抗氧化剂与氧化还原信号（ARS）是领先的同行评审期刊，致力于理解氧气和氧化还原（氧化还原）过程对人类健康和疾病的重要影响。该期刊探讨了基于氧化还原的遗传、药物和营养治疗的关键问题。尖端研究集中在结构生物学、干细胞、再生医学、表观遗传学、成像、临床结果以及预防和治疗营养等领域。ARS已扩展，在一份期刊中创建了两个独特的焦点：ARS发现和ARS治疗。ARS发现（24期）发布最优质的突破性基础和应用研究。ARS治疗（12期）是第一种展示氧化还原科学改变健康结果潜力的出版物。ARS的覆盖范围包括：-ROS/RNS作为信使-气体信号转导器-缺氧和组织氧合-microRNA-原核系统-植物生物学的教训